Sigrid Therapeutics raised €7.2M in a funding round in Nov 2021. The company is based in Stockholm, Sweden. Investors in the round: Barbara Bergström, Crosslight Partners, Hans Bergström and 3 others. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
